Czechia interested in buying COVID drug from Regeneron - Babis

Czechia is interested in the purchase of an anti-coronavirus drug from the U.S. company Regeneron which is based on monoclonal antibodies and Germany plans to use it as the first EU country, PM Andrej Babis (ANO) told CTK today. It is a non-registered drug that is promising, but its efficiency against COVID-19 has not been proven yet, Czech Drugs Control Institute (SUKL) spokeswoman Klara Brunclikova said.